Prospective survey of implantable defibrillator shock anxiety in Japanese patients: Results from the DEF‐Chiba study

  title={Prospective survey of implantable defibrillator shock anxiety in Japanese patients: Results from the DEF‐Chiba study},
  author={K. Miyazawa and Y. Kondo and Marehiko Ueda and T. Kajiyama and M. Nakano and M. Inagaki and J. Schwab and S. Sears and Yoshio Kobayashi},
  journal={Pacing and Clinical Electrophysiology},
  pages={1171 - 1177}
Patient‐reported outcomes of implantable cardioverter defibrillator (ICD), such as those with shock anxiety, have emerged as important endpoints that are related to quality of life (QOL), but they have not been well studied in a sample of the Japanese population. Therefore, we prospectively examined changes in shock anxiety in a large sample of Japanese patients with an ICD. 
Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use
Results are described from a focused literature review of studies using FSAS over the past 15 years, with the aim of summarizing its current reliability and validity, associated outcomes, and potential future directions for its clinical and research implementation. Expand
The utility of the Florida Shock Anxiety Scale: What have we learned?
The utility of the FSAS as a screening tool able to tailor appropriate treatment depending on the score it provides is reviewed, and the utilization of other tools such as FPAS, anxiety, and depression questionnaires as well as Quality of Life measures have proven to be helpful. Expand
Comparison of the performance of implantable cardioverter-defibrillator leads among manufacturers
In this single-center retrospective study, the performance of Sprint Quattro was lower than the performanceOf the three different manufacturers of ICD leads implanted in consecutive patients who underwent ICD system implantation at Chiba University Hospital, Japan, between March 2008 and September 2017, the survival probability over the entire follow-up time was lower for SprintQuattro leads than for either Durata or Linox/LinoxSmart. Expand
Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population
Recurrences of ventricular tachyarrhythmias and recurrent appropriate ICD therapies are associated with increased long-term all-cause mortality in consecutive ICD recipients and non-ischemic cardiomyopathy revealed to be significant predictors of both endpoints. Expand
Remote Monitoring of Cardiac Implantable Electronic Devices in Cardiovascular Diseases of the Elderly
With the rising of medical big data, tele-medicine has become more and more popular, especially in the field of cardiology. Cardiovascular diseases (CVDs), like atrial fibrillation, chronic heartExpand


Quality of Life Outcomes in Chinese Patients with Implantable Cardioverter Defibrillators
This study examined health‐related quality of life (HRQL) and its relation with I CD shock‐related anxiety, ICD shock, patient acceptance of the ICD, and demographic and clinical characteristics among a sample of Chinese ICD patients. Expand
The Florida Shock Anxiety Scale (FSAS) for Patients with Implantable Cardioverter Defibrillators: Testing Factor Structure, Reliability, and Validity of a Previously Established Measure
The purpose of this study was to examine the psychometrics of the FSAS in a large US sample of ICD patients, and initial psychometric evaluation revealed good reliability and validity. Expand
Age‐Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study
Investigating areas of adjustment across three age groups of women from multiple centers found fears of death or shock and body image concerns, as well as specific aspects and concerns that increase the chance of distress, are common. Expand
Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia
The aims were to assess the level of shock anxiety in a sample of ICD recipients, the relationship between such anxiety and shock exposure, and the relationships between recent tachyarrhythmia and shock anxiety. Expand
Effect of Depression on Mortality in Implantable Cardioverter Defibrillator Recipients—Findings from the Prospective LICAD Study
Depression predicts mortality in patients with coronary artery disease and heart failure and its effect on patient outcome in the presence of an implantable cardioverter defibrillator (ICD) has not been investigated. Expand
Depression and Anxiety Status of Patients with Implantable Cardioverter Defibrillator and Precipitating Factors
This work evaluates the emotional status of Turkish patients with ICD and tries to explain factors that affect emotional Status of the patients. Expand
Gender Differences in Psychological Distress and Quality of Life in Patients with an ICD 1‐Year Postimplant
The relationship between gender and patient‐reported outcomes in patients with an ICD in the first year after ICD implantation is examined to gain a better insight into potential determinants of psychological distress and health‐related quality of life. Expand
Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. Expand
Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale
The assessment of patient anxiety and concerns related to receiving an ICD shock may prompt appropriate psychological referrals and treatment. Expand
Quality of life in the Canadian Implantable Defibrillator Study (CIDS).
Quality of life is better with ICD therapy than with amiodarone therapy, and the beneficial quality-of-life effects from an ICD are not evident in patients who receive numerous shocks from their device. Expand